A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

Clinical trial NCT00210470 · COMPLETED

Trial details

NCT number: NCT00210470
Sponsor: Brooklyn ImmunoTherapeutics, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2005-07-01
Primary completion: 2010-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.